Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group studyMarilyn L. Slovak, Frederick R. Appelbaum, David R. Head et al.|Blood|2000Cited by 1.6k
A phase 3 study of gemtuzumab ozogamicin during induction and postconsolidation therapy in younger patients with acute myeloid leukemiaStephen H. Petersdorf, Frederick R. Appelbaum, Kenneth J. Kopecky et al.|Blood|2013Cited by 632
The drug resistance-related protein LRP is the human major vault proteinGeorge L. Scheffer, Rik J. Scheper, Peter Wijngaard et al.|Nature Medicine|1995Cited by 619
Persistence of malignant hematopoietic progenitors in chronic myelogenous leukemia patients in complete cytogenetic remission following imatinib mesylate treatmentRavi Bhatia, Stephen J. Forman, Melissa Holtz et al.|Blood|2003Cited by 541